Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 36.48
-0.10 (-0.27%)
Sep 24, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 11.61 billion as of September 25, 2026. Its market cap has decreased by -24.15% in one year.
Market Cap
11.61B
Enterprise Value
9.35B
Revenue
2.89B
Ranking
n/a
PE Ratio
11.94
Stock Price
36.48
ChartMarket Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 11.61B, an increase of 701.93%. That is a compound annual growth rate of 8.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 11.61B | -15.33% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Porton Pharma Solutions | 12.78B |
| Shenzhen Hepalink Pharmaceutical Group | 12.69B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.43B |
| PharmaBlock Sciences (Nanjing) | 12.13B |
| Beijing Aosaikang Pharmaceutical | 11.69B |
| Zhejiang Medicine | 11.69B |
| Shenzhen Chipscreen Biosciences | 11.21B |
| Shanghai Shyndec Pharmaceutical | 11.02B |